508 related articles for article (PubMed ID: 31804619)
1. Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis.
Takahashi-Kanemitsu A; Knight CT; Hatakeyama M
Cell Mol Immunol; 2020 Jan; 17(1):50-63. PubMed ID: 31804619
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of East Asian-type Helicobacter pylori strains.
Lind J; Backert S; Hoffmann R; Eichler J; Yamaoka Y; Perez-Perez GI; Torres J; Sticht H; Tegtmeyer N
BMC Microbiol; 2016 Sep; 16(1):201. PubMed ID: 27590005
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer.
Hatakeyama M
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(4):196-219. PubMed ID: 28413197
[TBL] [Abstract][Full Text] [Related]
4. Malignant Helicobacter pylori-Associated Diseases: Gastric Cancer and MALT Lymphoma.
Hatakeyama M
Adv Exp Med Biol; 2019; 1149():135-149. PubMed ID: 31016622
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis.
Hatakeyama M
Cell Host Microbe; 2014 Mar; 15(3):306-16. PubMed ID: 24629337
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cells.
Fujii Y; Murata-Kamiya N; Hatakeyama M
Cancer Sci; 2020 May; 111(5):1596-1606. PubMed ID: 32198795
[TBL] [Abstract][Full Text] [Related]
7. Dramatic increase in SHP2 binding activity of Helicobacter pylori Western CagA by EPIYA-C duplication: its implications in gastric carcinogenesis.
Nagase L; Hayashi T; Senda T; Hatakeyama M
Sci Rep; 2015 Oct; 5():15749. PubMed ID: 26507409
[TBL] [Abstract][Full Text] [Related]
8. Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus.
Saju P; Murata-Kamiya N; Hayashi T; Senda Y; Nagase L; Noda S; Matsusaka K; Funata S; Kunita A; Urabe M; Seto Y; Fukayama M; Kaneda A; Hatakeyama M
Nat Microbiol; 2016 Mar; 1():16026. PubMed ID: 27572445
[TBL] [Abstract][Full Text] [Related]
9. The number of Helicobacter pylori CagA EPIYA C tyrosine phosphorylation motifs influences the pattern of gastritis and the development of gastric carcinoma.
Ferreira RM; Machado JC; Leite M; Carneiro F; Figueiredo C
Histopathology; 2012 May; 60(6):992-8. PubMed ID: 22348604
[TBL] [Abstract][Full Text] [Related]
10. Pathogenetic role of the tyrosine-phosphorylated CagA EPIYA sequence of Helicobacter pylori in histological gastritis in Japanese patients.
Takata S; Ito M; Wada Y; Yoshihara M; Tanaka S; Chayama K
J Gastroenterol; 2009; 44(5):405-11. PubMed ID: 19347242
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori CagA -- a bacterial intruder conspiring gastric carcinogenesis.
Hatakeyama M
Int J Cancer; 2006 Sep; 119(6):1217-23. PubMed ID: 16557568
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori-induced DNA double-stranded break in the development of gastric cancer.
Murata-Kamiya N; Hatakeyama M
Cancer Sci; 2022 Jun; 113(6):1909-1918. PubMed ID: 35359025
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori CagA elicits BRCAness to induce genome instability that may underlie bacterial gastric carcinogenesis.
Imai S; Ooki T; Murata-Kamiya N; Komura D; Tahmina K; Wu W; Takahashi-Kanemitsu A; Knight CT; Kunita A; Suzuki N; Del Valle AA; Tsuboi M; Hata M; Hayakawa Y; Ohnishi N; Ueda K; Fukayama M; Ushiku T; Ishikawa S; Hatakeyama M
Cell Host Microbe; 2021 Jun; 29(6):941-958.e10. PubMed ID: 33989515
[TBL] [Abstract][Full Text] [Related]
14. CagA+ H pylori infection is associated with polarization of T helper cell immune responses in gastric carcinogenesis.
Wang SK; Zhu HF; He BS; Zhang ZY; Chen ZT; Wang ZZ; Wu GL
World J Gastroenterol; 2007 Jun; 13(21):2923-31. PubMed ID: 17589941
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcinogenesis via triggering oncogenic YAP pathway.
Li N; Feng Y; Hu Y; He C; Xie C; Ouyang Y; Artim SC; Huang D; Zhu Y; Luo Z; Ge Z; Lu N
J Exp Clin Cancer Res; 2018 Nov; 37(1):280. PubMed ID: 30466467
[TBL] [Abstract][Full Text] [Related]
16. Study of the cytoxin-associated gene a (CagA gene) in Helicobacter pylori using gastric biopsies of Iraqi patients.
Kalaf EA; Al-Khafaji ZM; Yassen NY; Al-Abbudi FA; Sadwen SN
Saudi J Gastroenterol; 2013; 19(2):69-74. PubMed ID: 23481132
[TBL] [Abstract][Full Text] [Related]
17. Amino acid polymorphisms flanking the EPIYA-A motif of Helicobacter pylori CagA C-terminal region is associated with gastric cancer in east China: experience from a single center.
Chen CY; Wang FY; Wan HJ; Jin XX; Wei J; Wang ZK; Liu C; Lu H; Shi H; Li DH; Liu J
J Dig Dis; 2013 Jul; 14(7):358-65. PubMed ID: 23517408
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori infection activates Src homology-2 domain-containing phosphatase 2 to suppress IFN-γ signaling.
Wang YC; Chen CL; Sheu BS; Yang YJ; Tseng PC; Hsieh CY; Lin CF
J Immunol; 2014 Oct; 193(8):4149-58. PubMed ID: 25225672
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis.
Hatakeyama M; Higashi H
Cancer Sci; 2005 Dec; 96(12):835-43. PubMed ID: 16367902
[TBL] [Abstract][Full Text] [Related]
20. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia.
Arnold IC; Hitzler I; Engler D; Oertli M; Agger EM; Müller A
J Immunol; 2011 Jun; 186(11):6165-72. PubMed ID: 21518972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]